Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 101 - 125 of 1049 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sunitinib	Approved Investigational	VEGFA	7422	increased	sunitinib results in increased expression of VEGFA protein	6p21.1	A26401
Zinc	Approved Investigational	IL10	3586	decreased	Zinc results in decreased expression of IL10 protein	1q32.1	A26402
Zinc	Approved Investigational	IL1RN	3557	increased	Zinc results in increased expression of IL1RN protein	2q14.1	A26402
Zinc	Approved Investigational	IL2	3558	increased	Zinc results in increased expression of IL2 protein	4q27	A26402
Zinc	Approved Investigational	TNFRSF1A	7132	increased	Zinc results in increased expression of TNFRSF1A protein	12p13.31	A26402
Morphine	Approved Investigational	APOB	338	increased	Morphine results in increased expression of APOB protein	2p24.1	A26403
Morphine	Approved Investigational	CRP	1401	increased	Morphine results in increased expression of CRP protein	1q23.2	A26403
Morphine	Approved Investigational	F7	2155	increased	Morphine results in increased expression of F7 protein	13q34	A26403
Atorvastatin	Approved	IL6	3569	decreased	Atorvastatin Calcium results in decreased expression of IL6 protein	7p15.3	A26404
Atorvastatin	Approved	TNF	7124	decreased	Atorvastatin Calcium results in decreased expression of TNF protein	6p21.33	A26404
Atorvastatin	Approved	CXCL8	3576	increased	Atorvastatin Calcium results in increased expression of CXCL8 protein	4q13.3	A26404
Atorvastatin	Approved	ICAM1	3383	increased	Atorvastatin Calcium results in increased expression of ICAM1 protein	19p13.2	A26404
Atorvastatin	Approved	SELE	6401	increased	Atorvastatin Calcium results in increased expression of SELE protein	1q24.2	A26404
Atorvastatin	Approved	VWF	7450	increased	Atorvastatin Calcium results in increased expression of VWF protein	12p13.31	A26404
Azathioprine	Approved	IL4	3565	decreased	Azathioprine results in decreased expression of IL4 protein	5q31.1	A26405
Prednisone	Approved Vet Approved	IL4	3565	decreased	Prednisone results in decreased expression of IL4 protein	5q31.1	A26405
Azathioprine	Approved	TNF	7124	increased	Azathioprine results in increased expression of TNF protein	6p21.33	A26405
Prednisone	Approved Vet Approved	TNF	7124	increased	Prednisone results in increased expression of TNF protein	6p21.33	A26405
Copper	Approved Investigational	PRL	5617	decreased	Copper results in decreased expression of PRL protein	6p22.3	A26406
Manganese	Approved Nutraceutical	PRL	5617	decreased	Manganese results in decreased expression of PRL protein	6p22.3	A26406
Molybdenum	Approved	PRL	5617	decreased	Molybdenum results in decreased expression of PRL protein	6p22.3	A26406
Zinc	Approved Investigational	PRL	5617	decreased	Zinc results in decreased expression of PRL protein	6p22.3	A26406
Chromium	Approved	PRL	5617	increased	Chromium results in increased expression of PRL protein	6p22.3	A26406
Amlodipine	Approved	INS	3630	decreased	Amlodipine results in decreased expression of INS protein	11p15.5	A26407
Atorvastatin	Approved	ADIPOQ	9370	decreased	Atorvastatin Calcium results in decreased expression of ADIPOQ protein	3q27.3	A26407

Displaying entries 101 - 125 of 1049 in total

Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability